Tactile Systems Technology, Inc. reported Q4 and full year 2025 financial results with total revenue of $103.6 million (+21% YoY) and $329.5 million (+12% YoY), respectively, alongside the acquisition of LymphaTech for $6.8 million upfront cash plus milestones. The company provided 2026 guidance of $357-365 million revenue and repaid its $26.3 million term loan.
Key takeaways
Q4 2025 total revenue $103.6 million, up 21% from $85.6 million in Q4 2024
Full year 2025 total revenue $329.5 million, up 12% from $293.0 million in 2024
Acquired LymphaTech for $6.8 million upfront cash plus contingent milestones
Repaid full $26.3 million term loan outstanding principal
Repurchased $26.5 million of stock at average $12.36 per share
2026 guidance: total revenue $357-365 million, adjusted EBITDA $49-51 million